Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateWages, Salaries and Other
Others
Ratios

Cytosorbents (CTSO) Preferred Dividend Payments (2017)

Cytosorbents' Preferred Dividend Payments history spans 5 years, with the latest figure at -$671462.0 for Q4 2017.

  • Quarterly results put Preferred Dividend Payments at -$671462.0 for Q4 2017, changed N/A from a year ago — trailing twelve months through Dec 2018 was -$671462.0 (changed 0.0% YoY), and the annual figure for FY2017 was -$335731.0, changed.
  • Preferred Dividend Payments for Q4 2017 was -$671462.0 at Cytosorbents, down from $1.3 million in the prior quarter.
  • In the past five years, Preferred Dividend Payments ranged from a high of $13.3 million in Q4 2013 to a low of -$671462.0 in Q4 2017.
  • The 3-year median for Preferred Dividend Payments is $865502.0 (2013), against an average of $2.3 million.
  • The sharpest move saw Preferred Dividend Payments decreased 16.61% in 2013, then skyrocketed 143.94% in 2014.
  • Year by year, Preferred Dividend Payments stood at $13.3 million in 2013, then crashed by 90.38% to $1.3 million in 2014, then plummeted by 152.41% to -$671462.0 in 2017.
  • According to Business Quant data, Preferred Dividend Payments over the past three periods came in at -$671462.0, $1.3 million, and $1.4 million for Q4 2017, Q3 2014, and Q2 2014 respectively.